Sort
15,842 grants matching “pancreatic cancer”
Optimizing the role of ERCP in evaluating indeterminate bile duct strictures
$176,319Gregory A Cote · Indiana University Indianapolis · K23 · FY2012 · DK
Deciphering SIRT6-dependent metabolic liabilities in Pancreatic cancer
$176,301Raul Mostoslavsky · Massachusetts General Hospital · R21 · FY2016 · CA
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
$176,231Andrea C Enzinger · Dana-Farber Cancer Inst · K07 · FY2017 · CA
AGX1/2 inhibitors as key modulators of the hexosamine biosynthetic pathway
$176,175Kevin J Yarema · Johns Hopkins University · R21 · FY2016 · CA
NMDA receptors in the diagnosis and treatment of pancreatic cancer
$176,175William G North · Dartmouth College · R21 · FY2013 · CA
Administrative and Biostatistics Core
$176,106Seung K Kim · Stanford University · P01 · FY2024 · CA
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities
$176,040Yevgeniy R Semenov · Massachusetts General Hospital · K23 · FY2024 · AR
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities
$176,040Yevgeniy R Semenov · Massachusetts General Hospital · K23 · FY2025 · AR
Subcellular one-carbon metabolism, S-Adenosylmethionine availability and cancer
$176,040Tiziano Bernasocchi · Massachusetts General Hospital · K99 · FY2025 · CA
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities
$176,040Yevgeniy R Semenov · Massachusetts General Hospital · K23 · FY2023 · AR
BASIS OF ANTIANGIOGENESIS THERAPY IN PANCREATIC CANCER
$175,840University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA
DNA methylation, Liquid Biopsy, and Pancreatic Cancer
$175,816Mark A Nelson · University Of Arizona · R21 · FY2023 · CA
CEST MRI assessment of tumor vascular permeability using non-labeled dextrans
$175,782Guanshu Liu · Hugo W. Moser Res Inst Kennedy Krieger · R21 · FY2017 · CA
CEST MRI assessment of tumor vascular permeability using non-labeled dextrans
$175,782Guanshu Liu · Hugo W. Moser Res Inst Kennedy Krieger · R21 · FY2018 · CA
UNMC Eppley Cancer Center Support Grant
$175,726Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2007 · CA
Training the Next Generation of Surgeon-Scientists in Pancreatology
$175,723Masato Yamamoto · University Of Minnesota · T32 · FY2020 · DK
Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro
$175,500Lei Zheng · Johns Hopkins University · K23 · FY2010 · CA
Novel Strategies to Broaden the Impact of HIFU Therapy in Cancer Management
$175,500Pei Zhong · Duke University · R21 · FY2009 · CA
Administrative Core
$175,422Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2016 · CA
Validation of MRI Microvascular Biomarkers in Pancreatic Cancer with Magnetic Nanoparticles
$175,392Alexander Savio Ramos Guimaraes · Oregon Health & Science University · K08 · FY2015 · EB
Administrative Core
$175,372Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2014 · CA
Biomedical Computing Tools for Pancreatic Can. Res. - Creighton U. consortium
$175,335Gleb R Haynatzki · University Of Nebraska Medical Center · R33 · FY2007 · CA
Minimally invasive ablative therapies for pancreatic cystic neoplasms
$175,314Carlos Cuevas · University Of Washington · R21 · FY2014 · CA
Mechanistic Dissection of an Arginine Methyltransferase Dependency in Cancer
$175,284Frederick H Wilson · Yale University · K08 · FY2021 · CA
Elucidating KRAS-specific vulnerabilities in pancreatic cancer
$175,284Mandar Deepak Muzumdar · Yale University · K08 · FY2018 · CA